{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:49:05Z","timestamp":1782949745670,"version":"3.54.5"},"publisher-location":"Cham","reference-count":91,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032127402","type":"print"},{"value":"9783032127419","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12741-9_12","type":"book-chapter","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T02:31:44Z","timestamp":1767321104000},"page":"359-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome"],"prefix":"10.1007","author":[{"given":"Alana","family":"Painter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilee","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley G.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"8","key":"12_CR1","first-page":"1151","volume":"9","author":"K Allegaert","year":"2022","unstructured":"Allegaert K, Oei JL (2022) Neonatal abstinence syndrome: prevention, management and outcomes: from birth to adulthood. Children (Basel). 9(8):1151. PMID 36010042","journal-title":"Children (Basel)."},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"632836","DOI":"10.3389\/fped.2021.632836","volume":"9","author":"MY Bader","year":"2021","unstructured":"Bader MY, Zaghloul N, Repholz A et al (2021) A retrospective review following the addition of clonidine to a neonatal abstinence syndrome treatment algorithm. Front Pediatr. 9:632836. PMID 34164354","journal-title":"Front Pediatr."},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.earlhumdev.2018.10.010","volume":"128","author":"LN Bakhireva","year":"2019","unstructured":"Bakhireva LN, Holbrook BD, Shrestha S et al (2019) Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5\u20138 months of age. Early Hum Dev. 128:69\u201376. PMID 30554024","journal-title":"Early Hum Dev."},{"issue":"4","key":"12_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41390-021-01756-4","volume":"91","author":"LN Bakhireva","year":"2022","unstructured":"Bakhireva LN, Sparks A, Herman M, Hund L, Ashley M, Salisbury A (2022) Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors. Pediatr Res. 91(4):867\u2013873. PMID 34588611","journal-title":"Pediatr Res."},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41372-023-01859-2","volume":"44","author":"RC Barnett","year":"2024","unstructured":"Barnett RC, Lewis AN, Gong Q et al (2024) Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome. J Perinatol 44:1125\u20131131. https:\/\/doi.org\/10.1038\/s41372-023-01859-2","journal-title":"J Perinatol"},{"issue":"4","key":"12_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1044\/2022_PERSP-21-00270","volume":"7","author":"KL Benninger","year":"2022","unstructured":"Benninger KL, Richard C, Conroy S et al (2022) One-year neurodevelopmental outcomes after neonatal opioid withdrawal syndrome: a prospective cohort study. Perspect ASHA Spec Interest Groups. 7(4):1019\u20131032. PMID 36211832","journal-title":"Perspect ASHA Spec Interest Groups."},{"issue":"1","key":"12_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clp.2022.10.007","volume":"50","author":"KL Benninger","year":"2023","unstructured":"Benninger KL, McAllister JM, Merhar SL (2023) Neonatal opioid withdrawal syndrome: an update on developmental outcomes. Clin Perinatol. 50(1):17\u201329. PMID 36868704","journal-title":"Clin Perinatol."},{"issue":"5","key":"12_CR500","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/s41390-022-02243-0","volume":"93","author":"S Bibi","year":"2023","unstructured":"Bibi S, Gaddis N, Johnson EO, Lester BM, Kraft W, Singh R, Terrin N, Adeniyi-Jones S, Davis JM (2023) Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome. Pediatr Res 93(5):1368\u20131374. https:\/\/doi.org\/10.1038\/s41390-022-02243-0. Epub 2022 Aug 16. PMID: 35974158; PMCID: PMC9931940","journal-title":"Pediatr Res"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jpsychires.2020.02.023","volume":"124","author":"A Biffi","year":"2020","unstructured":"Biffi A, Cantarutti A, Rea F, Locatelli A, Zanini R, Corrao G (2020) Use of antidepressants during pregnancy and neonatal outcomes: an umbrella review of meta-analyses of observational studies. J Psychiatr Res. 124:99\u2013108. PMID 32135392","journal-title":"J Psychiatr Res."},{"issue":"5","key":"12_CR501","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/ajo.12823","volume":"58","author":"J Blandthorn","year":"2018","unstructured":"Blandthorn J, Leung L, Loke Y, Lloyd-Jones DM, Thurman R, Bowman E, Bonomo Y (2018) Prescription opioid use in pregnancy. Aust N Z J Obstet Gynaecol 58(5):494\u2013498. https:\/\/doi.org\/10.1111\/ajo.12823","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"12_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1542\/hpeds.2018-0238","volume":"9","author":"T Blount","year":"2019","unstructured":"Blount T, Painter A, Freeman E, Grossman M, Sutton AG (2019) Reduction in length of stay and morphine use for NAS with the \u201ceat, sleep, console\u201d method. Hosp Pediatr. 9(8):615\u2013623. PMID 31285356","journal-title":"Hosp Pediatr."},{"issue":"3","key":"12_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1184","volume":"3","author":"M Brown-Lum","year":"2020","unstructured":"Brown-Lum M, Izadi-Najafabadi S, Oberlander TF, Rauscher A, Zwicker JG (2020) Differences in white matter microstructure among children with developmental coordination disorder. JAMA Netw Open. 3(3):e201184. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.1184","journal-title":"JAMA Netw Open."},{"issue":"12","key":"12_CR11","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","volume":"90","author":"MJ Brownstein","year":"1993","unstructured":"Brownstein MJ (1993) A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A. 90(12):5391\u20135393. https:\/\/doi.org\/10.1073\/pnas.90.12.5391. PMID:8390660; PMCID: PMC46725","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"12_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ajog.2019.07.022","volume":"221","author":"SN Caritis","year":"2019","unstructured":"Caritis SN, Panigrahy A (2019) Opioids affect the fetal brain: reframing the detoxification debate. Am J Obstet Gynecol 221(6):602\u2013608. https:\/\/doi.org\/10.1016\/j.ajog.2019.07.022. Epub 2019 Jul 16. PMID: 31323217; PMCID: PMC8150872","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"12_CR13","first-page":"67","volume":"9","author":"C Cestonaro","year":"2022","unstructured":"Cestonaro C, Menozzi L, Terranova C (2022) Infants of mothers with cocaine use: review of clinical and medico-legal aspects. Children (Basel). 9(1):67. PMID 35053692","journal-title":"Children (Basel)."},{"issue":"5","key":"12_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/AOG.0000000000003230","volume":"133","author":"V Coleman-Cowger","year":"2019","unstructured":"Coleman-Cowger V, Oga E, Peters E, Trocin K, Koszowski B, Mark K (2019) Accuracy of three screening tools for prenatal substance use. Obstetr Gynecol 133(5):952\u2013961. https:\/\/doi.org\/10.1097\/AOG.0000000000003230","journal-title":"Obstetr Gynecol"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpeds.2019.12.018","volume":"219","author":"AJ Czynski","year":"2020","unstructured":"Czynski AJ, Davis JM, Dansereau LM et al (2020) Neurodevelopmental outcomes of neonates randomized to morphine or methadone for treatment of neonatal abstinence syndrome. J Pediatr. 219:146\u2013151.e1. PMID 31987653","journal-title":"J Pediatr."},{"issue":"8","key":"12_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","volume":"172","author":"JM Davis","year":"2018","unstructured":"Davis JM, Shenberger J, Terrin N et al (2018) Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial. JAMA Pediatr. 172(8):741\u2013748. PMID 29913015","journal-title":"JAMA Pediatr."},{"issue":"3","key":"12_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00404-018-4833-2","volume":"298","author":"JF Dos Santos","year":"2018","unstructured":"Dos Santos JF, de Melo Bastos Cavalcante C, Barbosa FT et al (2018) Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis. Arch Gynecol Obstet. 298(3):487\u2013503. PMID 29951712","journal-title":"Arch Gynecol Obstet."},{"issue":"5","key":"12_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11916-024-01211-z","volume":"28","author":"AN Edinoff","year":"2024","unstructured":"Edinoff AN, Sall S, Upshaw WC, Spillers NJ, Vincik LY, De Witt AS, Murnane KS, Kaye AM, Kaye AD (2024) Xylazine: a drug adulterant of clinical concern. Curr Pain Headache Rep 28(5):417\u2013426. https:\/\/doi.org\/10.1007\/s11916-024-01211-z. Epub 2024 Mar 20. PMID: 38507135 PMCID: PMC11126434","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"12_CR502","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.annepidem.2013.05.017","volume":"23","author":"RA Epstein","year":"2013","unstructured":"Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, Cooper WO (2013) Increasing pregnancyrelated use of prescribed opioid analgesics. Ann Epidemiol 23(8):498\u2013503. https:\/\/doi.org\/10.1016\/j.annepidem.2013.05.017. PMID: 23889859; PMCID: PMC3888316","journal-title":"Ann Epidemiol"},{"issue":"1\u20132","key":"12_CR19","first-page":"19","volume":"12","author":"LP Finnegan","year":"1975","unstructured":"Finnegan LP, Kron RE, Connaughton JF, Emich JP (1975) Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm. 12(1\u20132):19\u201332. PMID 1100537","journal-title":"Int J Clin Pharmacol Biopharm."},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"108468","DOI":"10.1016\/j.pharmthera.2023.108468","volume":"248","author":"R Fujiwara","year":"2023","unstructured":"Fujiwara R, Journey M, Al-Doori F et al (2023) Potential neonatal toxicity of new psychoactive substances. Pharmacol Ther 248:108468. PMID 37290575","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"12_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1360-0443.2012.04039.x","volume":"107","author":"DE Gaalema","year":"2012","unstructured":"Gaalema DE, Scott TL, Heil SH et al (2012) Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction. 107(Suppl 1):53\u201362. PMID 23106927","journal-title":"Addiction."},{"issue":"9","key":"12_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.35074","volume":"7","author":"JR Gaither","year":"2024","unstructured":"Gaither JR, Drago MJ, Grossman MR, Li Y, Shabanova V, Xu X, Leventhal JM (2024) Hospital readmissions among infants with neonatal opioid withdrawal syndrome. JAMA Netw Open. 7(9):e2435074. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.35074. PMID: 39316398; PMCID: PMC11423163","journal-title":"JAMA Netw Open."},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fped.2018.00033","volume":"6","author":"E Gomez-Pomar","year":"2018","unstructured":"Gomez-Pomar E, Finnegan LP (2018) The epidemic of neonatal abstinence syndrome, historical references of its\u2019 origins, assessment, and management. Front Pediatr. 6:33. https:\/\/doi.org\/10.3389\/fped.2018.00033. PMID: 29520355; PMCID: PMC5827164","journal-title":"Front Pediatr."},{"issue":"9","key":"12_CR24","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1373\/clinchem.2010.147876","volume":"56","author":"TR Gray","year":"2010","unstructured":"Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA (2010) Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 56(9):1442\u20131450. PMID 20628142","journal-title":"Clin Chem."},{"issue":"12","key":"12_CR25","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1177\/0706743720904860","volume":"65","author":"S Grigoriadis","year":"2020","unstructured":"Grigoriadis S, Graves L, Peer M et al (2020) Pregnancy and delivery outcomes following benzodiazepine exposure: a systematic review and meta-analysis. Can J Psychiatry. 65(12):821\u2013834. PMID 32148076","journal-title":"Can J Psychiatry."},{"issue":"4","key":"12_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/acps.13441","volume":"146","author":"S Grigoriadis","year":"2022","unstructured":"Grigoriadis S, Alibrahim A, Mansfield JK, Sullovey A, Robinson GE (2022) Hypnotic benzodiazepine receptor agonist exposure during pregnancy and the risk of congenital malformations and other adverse pregnancy outcomes: a systematic review and meta-analysis. Acta Psychiatr Scand. 146(4):312\u2013324. PMID 35488412","journal-title":"Acta Psychiatr Scand."},{"issue":"7","key":"12_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamapediatrics.2023.1047","volume":"177","author":"S Grossarth","year":"2023","unstructured":"Grossarth S, Osmundson SS, Wiese AD et al (2023) Maternal opioid use disorder and the risk of postneonatal infant mortality. JAMA Pediatr. 177(7):675\u2013683. PMID 37155175","journal-title":"JAMA Pediatr."},{"issue":"1","key":"12_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","volume":"8","author":"MR Grossman","year":"2018","unstructured":"Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK (2018) A novel approach to assessing infants with neonatal abstinence syndrome. Hosp Pediatr 8(1):1\u20136. PMID 29263121","journal-title":"Hosp Pediatr"},{"issue":"4","key":"12_CR29","doi-asserted-by":"publisher","first-page":"e009986","DOI":"10.1136\/bmjopen-2015-009986","volume":"6","author":"JKL Gunn","year":"2016","unstructured":"Gunn JKL, Rosales CB, Center KE et al (2016) Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 6(4):e009986. PMID 27048634","journal-title":"BMJ Open."},{"issue":"3","key":"12_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41372-023-01623-6","volume":"43","author":"PD Hahn","year":"2023","unstructured":"Hahn PD, Melvin P, Graham DA, Ozonoff A, Milliren CE (2023) Association between pharmacologic treatment and hospital utilization at birth among neonatal opioid withdrawal syndrome mother-infant dyads. J Perinatol. 43(3):283\u2013292. PMID 36717607","journal-title":"J Perinatol."},{"issue":"1","key":"12_CR31","doi-asserted-by":"publisher","first-page":"e2023063635","DOI":"10.1542\/peds.2023-063635","volume":"154","author":"PD Hahn","year":"2024","unstructured":"Hahn PD, Graham DA, Ozonoff A, Milliren CE (2024) Neonatal opioid withdrawal syndrome treatment guidelines and birth hospital utilization. Pediatrics. 154(1):e2023063635. PMID 38899388","journal-title":"Pediatrics."},{"issue":"10","key":"12_CR32","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/phar.4616","volume":"44","author":"M Hasan","year":"2024","unstructured":"Hasan M, Meador KJ, Brothers TN et al (2024) Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: a population-based study. Pharmacotherapy. 44(10):770\u2013781. PMID 39415648","journal-title":"Pharmacotherapy."},{"issue":"1","key":"12_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0378-3782(01)00189-x","volume":"65","author":"E Herlenius","year":"2001","unstructured":"Herlenius E, Lagercrantz H (2001) Neurotransmitters and neuromodulators during early human development. Early Hum Dev. 65(1):21\u201337. https:\/\/doi.org\/10.1016\/s0378-3782(01)00189-x","journal-title":"Early Hum Dev."},{"issue":"2","key":"12_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","volume":"325","author":"AH Hirai","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW (2021) Neonatal abstinence syndrome and maternal opioid-related diagnoses in the us, 2010\u20132017. JAMA. 325(2):146\u2013155. PMID 33433576","journal-title":"JAMA."},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10995-020-02892-9","volume":"24","author":"J Hostage","year":"2020","unstructured":"Hostage J, Brock J, Craig W, Sepulveda D (2020) Integrating Screening, Brief Intervention and Referral to Treatment (SBIRT) for substance use into prenatal care. Matern Child Health J 24:412\u2013418. https:\/\/doi.org\/10.1007\/s10995-020-02892-9","journal-title":"Matern Child Health J"},{"issue":"2","key":"12_CR36","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","volume":"129","author":"ML Hudak","year":"2012","unstructured":"Hudak ML, Tan RC, The Committee on Drugs, The Committee on Fetus and Newborn, Frattarelli DAC, Galinkin JL, Green TP, Neville KA, Paul IM, Van Den Anker JN, Papile L-A, Baley JE, Bhutani VK, Carlo WA, Cummings J, Kumar P, Polin RA, Wang KS, Watterberg KL (2012) Neonatal drug withdrawal. Pediatrics 129(2):e540\u2013e560. https:\/\/doi.org\/10.1542\/peds.2011-3212","journal-title":"Pediatrics"},{"issue":"2","key":"12_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2049463720911986","volume":"14","author":"A James","year":"2020","unstructured":"James A, Williams J (2020) Basic opioid pharmacology \u2013 an update. Br J Pain 14(2):115\u2013121. https:\/\/doi.org\/10.1177\/2049463720911986. Epub 2020 Mar 20. PMID: 32537150; PMCID: PMC7265597","journal-title":"Br J Pain"},{"issue":"2","key":"12_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pcl.2018.12.006","volume":"66","author":"LM Jansson","year":"2019","unstructured":"Jansson LM, Patrick SW (2019) Neonatal abstinence syndrome. Pediatr Clin North Am. 66(2):353\u2013367. PMID 30819342","journal-title":"Pediatr Clin North Am."},{"issue":"1","key":"12_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1542\/peds.2007-1182","volume":"121","author":"LM Jansson","year":"2008","unstructured":"Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, Huestis MA (2008) Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 121(1):106\u2013114. https:\/\/doi.org\/10.1542\/peds.2007-1182","journal-title":"Pediatrics."},{"issue":"4","key":"12_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0890334416663198","volume":"32","author":"LM Jansson","year":"2016","unstructured":"Jansson LM, Spencer N, McConnell K, Velez M, Tuten M, Harrow CA, Jones HE, Swortwood MJ, Barnes AJ, Scheidweiler KB, Huestis MA (2016) Maternal buprenorphine maintenance and lactation. J Hum Lact. 32(4):675\u2013681. https:\/\/doi.org\/10.1177\/0890334416663198. Epub 2016 Sep 26","journal-title":"J Hum Lact."},{"issue":"1","key":"12_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/08903344231209304","volume":"40","author":"LM Jansson","year":"2024","unstructured":"Jansson LM, McConnell K, Velez M, Spencer N, Gomonit M, Swortwood MJ (2024) Buprenorphine-naloxone maintenance and lactation. J Hum Lact. 40(1):113\u2013119. https:\/\/doi.org\/10.1177\/08903344231209304. Epub 2023 Nov 29","journal-title":"J Hum Lact."},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2021.12.021","volume":"243","author":"SM Jilani","year":"2022","unstructured":"Jilani SM, Jones HE, Grossman M et al (2022) Standardizing the clinical definition of opioid withdrawal in the neonate. J Pediatr. 243:33\u201339.e1. PMID 34942181","journal-title":"J Pediatr."},{"issue":"24","key":"12_CR43","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G (2010) Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 363(24):2320\u20132331. https:\/\/doi.org\/10.1056\/NEJMoa1005359. PMID: 21142534; PMCID: PMC3073631","journal-title":"N Engl J Med."},{"issue":"3","key":"12_CR503","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1542\/hpeds.2022-006882","volume":"13","author":"NS Joshi","year":"2023","unstructured":"Joshi NS, Flaherman VJ, Halpern-Felsher B, Chung EK, Congdon JL, Lee HC (2023) Admission and care practices in United States well newborn nurseries. Hosp Pediatr 13(3):208\u2013216. https:\/\/doi.org\/10.1542\/hpeds.2022-006882. PMID: 36843483; PMCID: PMC9986853","journal-title":"Hosp Pediatr"},{"issue":"1","key":"12_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13367","volume":"145","author":"A Kautzky","year":"2022","unstructured":"Kautzky A, Slamanig R, Unger A, H\u00f6flich A (2022) Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis. Acta Psychiatr Scand. 145(1):6\u201328. PMID 34486740","journal-title":"Acta Psychiatr Scand."},{"issue":"2","key":"12_CR45","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"P Kocherlakota","year":"2014","unstructured":"Kocherlakota P (2014) Neonatal abstinence syndrome. Pediatrics. 134(2):e547\u2013e561. https:\/\/doi.org\/10.1542\/peds.2013-3524","journal-title":"Pediatrics."},{"issue":"11","key":"12_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11920-022-01372-x","volume":"24","author":"LG Lebin","year":"2022","unstructured":"Lebin LG, Novick AM (2022) Selective serotonin reuptake inhibitors (Ssris) in pregnancy: an updated review on risks to mother, fetus, and child. Curr Psychiatry Rep. 24(11):687\u2013695. PMID 36181572","journal-title":"Curr Psychiatry Rep."},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.earlhumdev.2017.11.010","volume":"116","author":"TA Levine","year":"2018","unstructured":"Levine TA, Woodward LJ (2018) Early inhibitory control and working memory abilities of children prenatally exposed to methadone. Early Hum Dev. 116:68\u201375. PMID 29195088","journal-title":"Early Hum Dev."},{"issue":"9","key":"12_CR48","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/dmcn.14808","volume":"63","author":"TA Levine","year":"2021","unstructured":"Levine TA, Davie-Gray A, Kim HM, Lee SJ, Woodward LJ (2021) Prenatal methadone exposure and child developmental outcomes in 2-year-old children. Dev Med Child Neurol. 63(9):1114\u20131122. PMID 33462809","journal-title":"Dev Med Child Neurol."},{"issue":"2","key":"12_CR49","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3664","volume":"144","author":"S Lisonkova","year":"2019","unstructured":"Lisonkova S, Richter LL, Ting J, Muraca GM, Wen Q, Mehrabadi A, Mitchell-Foster S, Oviedo-Joekes E, Lyons J (2019) Neonatal abstinence syndrome and associated neonatal and maternal mortality and morbidity. Pediatrics 144(2):e20183664. https:\/\/doi.org\/10.1542\/peds.2018-3664. PMID 31300529","journal-title":"Pediatrics"},{"issue":"4","key":"12_CR504","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","volume":"172","author":"KDL MacMillan","year":"2018","unstructured":"MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB, Volpe Holmes A (2018) Association of Rooming-in with Outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pediatr 172(4):345\u2013351. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.5195. PMID: 29404599; PMCID: PMC5875350","journal-title":"JAMA Pediatr"},{"issue":"4","key":"12_CR50","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.clp.2019.08.012","volume":"46","author":"KDL MacMillan","year":"2019","unstructured":"MacMillan KDL (2019) Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes. Clin Perinatol. 46(4):817\u2013832. https:\/\/doi.org\/10.1016\/j.clp.2019.08.012. Epub 2019 Aug 14","journal-title":"Clin Perinatol."},{"issue":"1","key":"12_CR51","doi-asserted-by":"publisher","first-page":"e2145653","DOI":"10.1001\/jamanetworkopen.2021.45653","volume":"5","author":"G Marchand","year":"2022","unstructured":"Marchand G, Masoud AT, Govindan M et al (2022) Birth outcomes of neonates exposed to marijuana in utero: a systematic review and meta-analysis. JAMA Netw Open. 5(1):e2145653. PMID 35084479","journal-title":"JAMA Netw Open."},{"issue":"2","key":"12_CR52","doi-asserted-by":"publisher","first-page":"e2023062871","DOI":"10.1542\/peds.2023-062871","volume":"153","author":"M Mascarenhas","year":"2024","unstructured":"Mascarenhas M, Wachman EM, Chandra I, Xue R, Sarathy L, Schiff DM (2024) Advances in the care of infants with prenatal opioid exposure and neonatal opioid withdrawal syndrome. Pediatrics. 153(2):e2023062871. PMID 38178779","journal-title":"Pediatrics."},{"key":"12_CR53","unstructured":"Mascola M, Borders A, Terplan M (2017) ACOG Committee Opinion No. 524: opioid use and opioid use disorder in pregnancy. Obstet Gynecol:711"},{"issue":"9","key":"12_CR505","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1542\/hpeds.2021-005904","volume":"11","author":"CE Milliren","year":"2021","unstructured":"Milliren CE, Melvin P, Ozonoff A (2021) Pediatric hospital readmissions for infants with neonatal opioid withdrawal syndrome, 2016-2019. Hosp Pediatr 11(9):979\u2013988. https:\/\/doi.org\/10.1542\/hpeds.2021-005904","journal-title":"Hosp Pediatr"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nicl.2017.12.033","volume":"18","author":"VJ Monnelly","year":"2017","unstructured":"Monnelly VJ, Anblagan D, Quigley A, Cabez MB, Cooper ES, Mactier H, Semple SI, Bastin ME, Boardman JP (2017) Prenatal methadone exposure is associated with altered neonatal brain development. Neuroimage Clin. 18:9\u201314. https:\/\/doi.org\/10.1016\/j.nicl.2017.12.033. PMID: 29326869; PMCID: PMC5760461","journal-title":"Neuroimage Clin."},{"issue":"4","key":"12_CR507","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1055\/s-0040-1716490","volume":"39","author":"E Morris","year":"2022","unstructured":"Morris E, Bardsley T, Schulte K, Seidel J, Shakib JH, Buchi KF, Fung CM (2022) Hospital outcomes of infants with neonatal opioid withdrawal syndrome at a tertiary care hospital with high rates of concurrent nonopioid (polysubstance) exposure. Am J Perinatol 39(4):387\u2013393. https:\/\/doi.org\/10.1055\/s-0040-1716490. Epub 2020 Sep 6. PMID: 32892326; PMCID: PMC8632549","journal-title":"Am J Perinatol"},{"issue":"2","key":"12_CR55","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1148\/radiol.2212001702","volume":"221","author":"P Mukherjee","year":"2001","unstructured":"Mukherjee P et al (2001) Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology 221(2):349\u2013358","journal-title":"Radiology"},{"key":"12_CR56","doi-asserted-by":"crossref","unstructured":"Munn Z, Pollock D, Stone J et al (2024) The impact of using cannabis during pregnancy on the infant and mother: an overview of systematic reviews, evidence map, targeted updates, and de novo synthesis. Aust N Z J Obstet Gynaecol. PMID 39699257","DOI":"10.1111\/ajo.13916"},{"issue":"11","key":"12_CR508","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1542\/neo.23-10-e788","volume":"23","author":"D Murosko","year":"2022","unstructured":"Murosko D, Paul K, Barfield WD, Montoya-Williams D, Parga-Belinkie J (2022) Equity in policies regarding urine drug testing in infants. NeoReviews 23(11):788\u2013795. https:\/\/doi.org\/10.1542\/neo.23-10-e788. PMID: 36316251; PMCID: PMC10044569","journal-title":"NeoReviews"},{"key":"12_CR57","doi-asserted-by":"crossref","unstructured":"Obstet Gynecol (2017) Committee opinion no. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 130(2):e81\u2013e94. PMID 28742676","DOI":"10.1097\/AOG.0000000000002235"},{"key":"12_CR58","first-page":"287","volume-title":"Pandora\u2019s lab: seven stories of science gone wrong","author":"PA Offit","year":"2016","unstructured":"Offit PA (2016) Pandora\u2019s lab: seven stories of science gone wrong. National Geographic, Washington, DC, p 287"},{"issue":"12","key":"12_CR59","first-page":"CD013217","volume":"12","author":"A Pahl","year":"2020","unstructured":"Pahl A, Young L, Buus-Frank ME, Marcellus L, Soll R (2020) Non-pharmacological care for opioid withdrawal in newborns. Cochrane Database Syst Rev. 12(12):CD013217. PMID 33348423","journal-title":"Cochrane Database Syst Rev."},{"key":"12_CR60","doi-asserted-by":"publisher","unstructured":"Patel E, Bandara S, Saloner B, Stuart E, Goodman D, Terplan M, McCourt A, White S, McGinty W (2021) Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016\u20132018. Am J Obstetr Gynecol MFM. 3(5). https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100419","DOI":"10.1016\/j.ajogmf.2021.100419"},{"issue":"18","key":"12_CR61","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM (2012) Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009. JAMA. 307(18):1934\u20131940. PMID 22546608","journal-title":"JAMA."},{"issue":"5","key":"12_CR62","doi-asserted-by":"publisher","first-page":"e2020029074","DOI":"10.1542\/peds.2020-029074","volume":"146","author":"SW Patrick","year":"2020","unstructured":"Patrick SW, Barfield WD, Poindexter BB, Committee on Fetus and Newborn, Committee on Substance Use and Prevention (2020) Neonatal opioid withdrawal syndrome. Pediatrics. 146(5):e2020029074. PMID 33106341","journal-title":"Pediatrics."},{"issue":"10","key":"12_CR63","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jama.1947.62890100006006c","volume":"135","author":"MA Perlstein","year":"1947","unstructured":"Perlstein MA (1947) Congenital morphinism; a rare cause of convulsions in the newborn. J Am Med Assoc. 135(10):633. https:\/\/doi.org\/10.1001\/jama.1947.62890100006006c","journal-title":"J Am Med Assoc."},{"issue":"9","key":"12_CR64","first-page":"337","volume":"27","author":"GE Petty","year":"1912","unstructured":"Petty GE (1912) 1 Congenital morphinism, with report of cases. Tex Med J (Austin). 27(9):337\u2013343. PMCID: PMC9642179 PMID: 36956630","journal-title":"Tex Med J (Austin)."},{"issue":"1","key":"12_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12978-020-0880-9","volume":"17","author":"C Roncero","year":"2020","unstructured":"Roncero C, Valriberas-Herrero I, Mezzatesta-Gava M, Villegas JL, Aguilar L, Grau-L\u00f3pez L (2020) Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health. 17(1):25. PMID 32066469","journal-title":"Reprod Health."},{"issue":"1","key":"12_CR66","doi-asserted-by":"publisher","first-page":"2162820","DOI":"10.1080\/14767058.2022.2162820","volume":"36","author":"E Salt","year":"2023","unstructured":"Salt E, Wiggins A, Pick A, Bada H, Howard C, Currie M, Rayens MK (2023) A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome. J Matern Fetal Neonatal Med. 36(1):2162820. https:\/\/doi.org\/10.1080\/14767058.2022.2162820","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"8","key":"12_CR67","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","volume":"9","author":"LA Sanlorenzo","year":"2019","unstructured":"Sanlorenzo LA, Cooper WO, Dudley JA, Stratton S, Maalouf FI, Patrick SW (2019) Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure. Hosp Pediatr. 9(8):569\u2013575. PMID 31262946","journal-title":"Hosp Pediatr."},{"key":"12_CR68","doi-asserted-by":"crossref","unstructured":"Shrestha S, Roberts MH, Maxwell JR, Leeman LM, Bakhireva LN (2021) Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome. Neurotoxicol Teratol. 86:106975. PMID 33766722","DOI":"10.1016\/j.ntt.2021.106975"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"106033","DOI":"10.1016\/j.neubiorev.2025.106033","volume":"170","author":"MB Spodnick","year":"2025","unstructured":"Spodnick MB, McElderry SC, Diaz MR (2025) Opioid receptor signaling throughout ontogeny: shaping neural and behavioral trajectories. Neurosci Biobehav Rev 170:106033. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106033. Epub 2025 Jan 31. PMID: 39894419; PMCID: PMC11851333","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"12_CR509","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jamapediatrics.2019.4791","volume":"174","author":"AE Strahan","year":"2020","unstructured":"Strahan AE, Guy GP Jr, Bohm M, Frey M, Ko JY (2020) Neonatal abstinence syndrome incidence and health care costs in the United States, 2016. JAMA Pediatr 174(2):200\u2013202. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.4791. PMID: 31841581; PMCID: PMC6990852","journal-title":"JAMA Pediatr"},{"issue":"1","key":"12_CR510","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/aje\/kwab249","volume":"191","author":"L Straub","year":"2022","unstructured":"Straub L, Huybrechts KF, Hern\u00e1ndez-D\u00edaz S, Zhu Y, Vine S, Desai RJ, Gray KJ, Bateman BT (2022) Trajectories of prescription opioid utilization during pregnancy among Prepregnancy chronic users and risk of neonatal opioid withdrawal syndrome. Am J Epidemiol 191(1):208\u2013219. https:\/\/doi.org\/10.1093\/aje\/kwab249. PMID: 34643225; PMCID: PMC8897996","journal-title":"Am J Epidemiol"},{"issue":"22","key":"12_CR70","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","volume":"387","author":"EA Suarez","year":"2022","unstructured":"Suarez EA, Huybrechts KF, Straub L, Hern\u00e1ndez-D\u00edaz S, Jones HE, Connery HS, Davis JM, Gray KJ, Lester B, Terplan M, Mogun H, Bateman BT (2022) Buprenorphine versus methadone for opioid use disorder in pregnancy. N Engl J Med. 387(22):2033\u20132044. https:\/\/doi.org\/10.1056\/NEJMoa2203318. PMID 36449419","journal-title":"N Engl J Med."},{"issue":"1","key":"12_CR71","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0541","volume":"143","author":"CV Towers","year":"2019","unstructured":"Towers CV, Hyatt BW, Visconti KC, Chernicky L, Chattin K, Fortner KB (2019) Neonatal head circumference in newborns with neonatal abstinence syndrome. Pediatrics. 143(1):e20180541. https:\/\/doi.org\/10.1542\/peds.2018-0541. Epub 2018 Dec 10","journal-title":"Pediatrics."},{"issue":"4","key":"12_CR72","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/AOG.0000000000004305","volume":"137","author":"M Ulrich","year":"2021","unstructured":"Ulrich M, Memmo E, Cruz A, Heinz A, Iverson R (2021) Implementation of a universal screening process for substance use in pregnancy. Obstetr Gynecol. 137(4):695\u2013701. https:\/\/doi.org\/10.1097\/AOG.0000000000004305","journal-title":"Obstetr Gynecol."},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"108045","DOI":"10.1016\/j.pharmthera.2021.108045","volume":"234","author":"MW Van Hoogdalem","year":"2022","unstructured":"Van Hoogdalem MW, Wexelblatt SL, Akinbi HT, Vinks AA, Mizuno T (2022) A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacol Ther 234:108045, ISSN 0163-7258. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108045","journal-title":"Pharmacol Ther"},{"issue":"1","key":"12_CR74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-0034-1374817","volume":"32","author":"KC Visconti","year":"2015","unstructured":"Visconti KC, Hennessy KC, Towers CV, Howard BC (2015) Chronic opiate use in pregnancy and newborn head circumference. Am J Perinatol. 32(1):27\u201332. https:\/\/doi.org\/10.1055\/s-0034-1374817. Epub 2014 May 2","journal-title":"Am J Perinatol."},{"issue":"5","key":"12_CR75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000516031","volume":"90","author":"J Wang","year":"2021","unstructured":"Wang J, Cosci F (2021) Neonatal withdrawal syndrome following late in utero exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis of observational studies. Psychother Psychosom. 90(5):299\u2013307. PMID 33971648","journal-title":"Psychother Psychosom."},{"issue":"3","key":"12_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2024.100384","volume":"4","author":"A White","year":"2024","unstructured":"White A, Afsari M, Balakrishnan H, Chapa E, Kim M, Mehra S, Faucher MA, Miller J, Cordova P, Duryea EL, Nelson DB, Ambia AM, Mcintire DD, Adhikari EH (2024) Implementation of universal screening for substance use in pregnancy in a public healthcare system. AJOG Glob Rep. 4(3):100384. https:\/\/doi.org\/10.1016\/j.xagr.2024.100384","journal-title":"AJOG Glob Rep."},{"issue":"10","key":"12_CR77","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/jp.2017.106","volume":"37","author":"CE Witt","year":"2017","unstructured":"Witt CE, Rudd KE, Bhatraju P, Rivara FP, Hawes SE, Weiss NS (2017) Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study. J Perinatol. 37(10):1124\u20131129. https:\/\/doi.org\/10.1038\/jp.2017.106. PMID 28682319","journal-title":"J Perinatol."},{"key":"12_CR78","doi-asserted-by":"publisher","first-page":"1305508","DOI":"10.3389\/fped.2023.1305508","volume":"11","author":"TA Wouldes","year":"2023","unstructured":"Wouldes TA, Lester BM (2023) Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant. Front Pediatr. 11:1305508. PMID 38250592","journal-title":"Front Pediatr."},{"issue":"25","key":"12_CR79","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa2214470","volume":"388","author":"LW Young","year":"2023","unstructured":"Young LW, Ounpraseuth ST, Merhar SL et al (2023) Eat, sleep, console approach or usual care for neonatal opioid withdrawal. N Engl J Med. 388(25):2326\u20132337. PMID 37125831","journal-title":"N Engl J Med."},{"issue":"7","key":"12_CR80","first-page":"CD002059","volume":"7","author":"A Zankl","year":"2021","unstructured":"Zankl A, Martin J, Davey JG, Osborn DA (2021) Opioid treatment for opioid withdrawal in newborn infants. Cochrane Database Syst Rev. 7(7):CD002059. PMID 34231914","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"12_CR81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000517753","volume":"43","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Gong F, Liu P, He Y, Wang H (2021) Effects of prenatal methamphetamine exposure on birth outcomes, brain structure, and neurodevelopmental outcomes. Dev Neurosci. 43(5):271\u2013280. PMID 34139695","journal-title":"Dev Neurosci."}],"container-title":["Advances in Experimental Medicine and Biology","Molecular Mechanisms and Lifelong Consequences of Prenatal Exposure to Psychoactive Substances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12741-9_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T02:31:46Z","timestamp":1767321106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12741-9_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032127402","9783032127419"],"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12741-9_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 January 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}